Johnson & Johnson Knew about Carcinogens in Baby Powder for Decades: Reuters
HEALTH, 17 Dec 2018
The company reportedly has known about the asbestos in its signature product since the early 1970s.
15 Dec 2018 – Was there a carcinogen in the baby powder, all this time?
According to an investigation by Reuters, “Johnson & Johnson knew for decades that asbestos lurked in its baby powder.”
Some of the 11,700 plaintiffs in a lawsuit against the company — including thousands of women with ovarian cancer — claim that the company’s talc caused their illness. The investigation relied upon trial testimony, depositions, and “thousands of pages of company memos, internal reports and other confidential documents,” the wire agency said.
Reuters found that “from at least 1971 to the early 2000s, the company’s raw talc and finished powders sometimes tested positive for small amounts of asbestos, and that company executives, mine managers, scientists, doctors and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public.”
“The documents also depict successful efforts to influence U.S. regulators’ plans to limit asbestos in cosmetic talc products and scientific research on the health effects of talc,” according to the report published on Friday.
Asbestos is frequently found underground near talc, the primary ingredient in baby powder. It was a source of worry within Johnson & Johnson as early as 1957, when reports by a consulting lab mentioned tainted talc.
There is no safe level of exposure to asbestos, according to the World Health Organization. Even trace amounts are dangerous. That asbestos is the primary cause of mesothelioma has been widely understood since the early 1970s; in 1972, the first ruling of the Occupational Safety and Health Administration — a new creation courtesy of President Nixon — was a limit on workplace exposure to asbestos dust.
The New York Times also analyzed hundreds of documents in the Johnson & Johnson cases. Based on those corporate documents, government records, and interviews with lawyers and scientists, the Times found that “executives proposed new testing procedures or replacing talc outright, while trying to discredit research suggesting that the powder could be contaminated with asbestos.”
Tactics to keep this potentially product-killing information from the public included “demand[ing] the government block unfavorable findings,” the Times reported. To that end, an FDA official promised Johnson & Johnson that the damning findings would only be revealed to the world “over my dead body.”
Johnson & Johnson stands by its signature product. The official line is that the baby powder has never contained asbestos; allegations to the contrary are rooted in “junk science.”
In recent years, Johnson & Johnson has been on the receiving end of a wave of lawsuits over its baby powder. As the Times points out, this summer saw 22 women with ovarian cancer sue Johnson & Johnson, arguing that the company knew about the talc-asbestos link and did nothing about it. Their reward — $4.69 billion — was one of the largest personal injury verdicts in history.
The company lost two other cases this year, in California and New Jersey, brought by people with mesothelioma, a cancer of the lining of internal organs that is associated with asbestos.
The prospect of asbestos “puts the defense in a much more difficult position,” said Nathan Schachtman, a lawyer who has defended asbestos companies. “You get a much higher degree of indignation from juries.”
But in some cases, Johnson & Johnson has prevailed. As Reuters reports, “at least three juries have rejected claims that Baby Powder was tainted with asbestos or caused plaintiffs’ mesothelioma. Others have failed to reach verdicts, resulting in mistrials.” Johnson & Johnson has announced plans to appeal the verdicts against the company.
Perhaps surprising to the public, which associates Johnson & Johnson primarily with its baby powder, the powder isn’t even the company’s highest-selling product — far from it. But the brand’s image is inextricably linked to the company.
DISCLAIMER: In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Join the discussion!
We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.
Click here to go to the current weekly digest or pick another article: